PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma. - Wikidata - awgldk - TriplyDB

PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma.

PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma.

http://www.wikidata.org/entity/Q37697320

about

PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma.

http://www.wikidata.org/entity/Q37697320

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PEG-asparaginase in BFM-90 reg ...... gnosed lymphoblastic lymphoma.

@en

PEG-asparaginase in BFM-90 reg ...... gnosed lymphoblastic lymphoma.

@nl

type

label

PEG-asparaginase in BFM-90 reg ...... gnosed lymphoblastic lymphoma.

@en

PEG-asparaginase in BFM-90 reg ...... gnosed lymphoblastic lymphoma.

@nl

prefLabel

PEG-asparaginase in BFM-90 reg ...... gnosed lymphoblastic lymphoma.

@en

PEG-asparaginase in BFM-90 reg ...... gnosed lymphoblastic lymphoma.

@nl

P1433

Q37697320-CB2A5858-A211-4D4E-A275-8B9F50366338

P1476

Q37697320-DA958F21-396A-4EA3-BE67-BF0B09EE6A9D

P2093

Q37697320-10A12782-5D9A-43AE-97EA-2C70A6814018

Q37697320-2ED32B4B-57ED-4A73-8702-2C8944FA90D4

Q37697320-32B4A4A9-CAB0-495C-BE05-045AEC68E41F

Q37697320-6FFF712C-EC0F-4A75-A6AD-2E6B5AD13CA1

Q37697320-778F84CF-7181-45A9-B7DA-0FAC09E302FE

Q37697320-7837EDFC-3D1B-43BE-9CED-B3211D6FF4CF

Q37697320-9905AB47-62C3-4939-8341-BDFA7037FE7E

Q37697320-9AA6F1A5-FD50-4703-AD5A-9EF1D7CA3029

Q37697320-9BFBF60B-215F-4DD8-9F9F-E335D9B986FC

Q37697320-A19F3A20-DC57-4770-B0A6-5373ECB8EEF7

P2860

Q37697320-01E77B4C-C9D5-446F-A1BF-88BC22221E19

Q37697320-0D5825DA-91ED-43C9-BD14-C62AFDA09931

Q37697320-11350281-9EAA-4C91-806E-327088EF3160

Q37697320-1865A721-5B18-46DD-9D25-0B1551331715

Q37697320-247E0060-DE11-44B1-8C82-111BE39910E9

Q37697320-3F97B3CF-E7E9-4971-A1C5-E527126E596D

Q37697320-43D8BDB8-F38C-4AA1-AC64-93C1782F118F

Q37697320-61F5B39F-112A-4A16-AE63-4D0B0CDFE989

Q37697320-67603AF6-60BE-429D-8E45-0F947B1E9250

Q37697320-68EC2885-DD38-4B51-AD18-A17ABF91F35F

P304

Q37697320-8F188A3D-255F-4D6D-8003-9B255F5C23F3

P31

Q37697320-144A9B1B-9E39-4CCC-920D-FB9465A555A3

P356

Q37697320-23CD253B-44AB-43C4-8FF0-327C74B585EE

P433

Q37697320-133A85C1-4399-48B1-BB14-5CEA14909C2B

P478

Q37697320-FE8EE0A5-B577-4594-A443-0F89E77102DF

P577

Q37697320-5D1A734E-CFDD-40C6-BD05-030390349C70

P698

Q37697320-A744CB2A-493D-4CC4-9023-5763604FE78D

P932

Q37697320-7E1DD434-8EFA-4996-BFAE-B0E523AC4CF9

P356

J.ISSN.1000-9604.2017.01.08

P1433

Chinese journal of cancer research : official journal of China Anti-Cancer Association, Beijing Institute for Cancer Research

P1476

PEG-asparaginase in BFM-90 reg ...... gnosed lymphoblastic lymphoma.

@en

P2093

Chen Zhang

http://www.w3.org/2001/XMLSchema#string

Hanyun Ren

http://www.w3.org/2001/XMLSchema#string

Jun Zhu

http://www.w3.org/2001/XMLSchema#string

Lijuan Deng

http://www.w3.org/2001/XMLSchema#string

Lingyan Ping

http://www.w3.org/2001/XMLSchema#string

Mei Xue

http://www.w3.org/2001/XMLSchema#string

Meifeng Tu

http://www.w3.org/2001/XMLSchema#string

Ningjing Lin

http://www.w3.org/2001/XMLSchema#string

Weiping Liu

http://www.w3.org/2001/XMLSchema#string

Wen Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice guideline: management of acute pancreatitis

How I treat acute lymphoblastic leukemia in older adolescents and young adults

Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemia.

Autologous hematopoietic stem cell transplantation in chemotherapy-sensitive lymphoblastic lymphoma: treatment outcome and prognostic factor analysis.

Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511

Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.

Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel.

The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia.

L-asparaginase: an effective agent in the treatment of acute lymphoblastic leukemia.

P304

66-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21147/J.ISSN.1000-9604.2017.01.08

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28373755

http://www.w3.org/2001/XMLSchema#string

P932

5348477

http://www.w3.org/2001/XMLSchema#string